61 results on '"Wojdyla, Daniel"'
Search Results
2. Case Volumes and Outcomes Among Early-Career Interventional Cardiologists in the United States
3. Mavacamten for Obstructive Hypertrophic Cardiomyopathy With or Without Hypertension: Post-Hoc Analysis of the EXPLORER-HCM Trial
4. Antithrombotic Strategies According to Age: Insights from the AUGUSTUS Trial
5. Trans-Balance: Reducing demographic disparity for prediction models in the presence of class imbalance
6. Morbidity and Mortality Associated With Heart Failure in Acute Coronary Syndrome: A Pooled Analysis of 4 Clinical Trials
7. Heart rate and death and hospitalization for heart failure in patients with persistent or permanent atrial fibrillation: Insights from the ARISTOTLE trial
8. Outcomes and Institutional Variation in Arterial Access Among Patients With AMI and Cardiogenic Shock Undergoing PCI
9. Comparing the Classification of Percutaneous Coronary Interventions Using the 2012 and 2017 Appropriate Use Criteria: Insights From 245,196 Patients in the NCDR CathPCI Registry
10. Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention
11. Contemporary Use of Venoarterial Extracorporeal Membrane Oxygenation: Insights from the Multicenter RESCUE Registry
12. Can the Absence of Hypertension Refine the Risk Assessment of Older Adults for Future Cardiovascular Events?
13. Long-term health-related quality of life and symptom severity following hysterectomy, myomectomy, or uterine artery embolization for the treatment of symptomatic uterine fibroids
14. Association Between Triglycerides and Residual Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus and Established Cardiovascular Disease (From the Bypass Angioplasty Revascularization Investigation 2 Diabetes [BARI 2D] Trial)
15. The association between triglycerides and incident cardiovascular disease: What is “optimal”?
16. Impact of Age on Comorbidities and Outcomes in Heart Failure With Reduced Ejection Fraction
17. Characteristics and Outcomes of Atrial Fibrillation in Patients With Thyroid Disease (from the ARISTOTLE Trial)
18. Relationship Between Optimism and Outcomes in Patients With Chronic Angina Pectoris
19. Comparison of Outcomes and Frequency of Graft Failure With Use of Free Versus In Situ Internal Mammary Artery Bypass Conduits (from the PREVENT IV Trial)
20. LB-1 | Temporal Trends and Clinical Outcomes with Radial Versus Femoral Arterial Access for Percutaneous Coronary Intervention in the United States
21. Dual antiplatelet therapy for perioperative myocardial infarction following CABG surgery
22. Digoxin and Mortality in Patients With Atrial Fibrillation
23. Clinical Outcomes and History of Fall in Patients with Atrial Fibrillation Treated with Oral Anticoagulation: Insights From the ARISTOTLE Trial
24. Appropriateness and Outcomes of Percutaneous Coronary Intervention at Top-Ranked and Nonranked Hospitals in the United States
25. Intracranial hemorrhage in patients with atrial fibrillation receiving anticoagulation therapy
26. Heart Rate or Beta-Blocker Dose? Association With Outcomes in Ambulatory Heart Failure Patients With Systolic Dysfunction: Results From the HF-ACTION Trial
27. Temporal Trends in Risk Factors of Periprocedural Stroke in Patients Undergoing Percutaneous Coronary Intervention: Insights from the ACC NCDR CathPCI Registry
28. Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures
29. Central venous pressure after coronary artery bypass surgery: Does it predict postoperative mortality or renal failure?
30. Characteristics and Outcomes of Patients With Heart Failure and Discordant Findings by Right-Sided Heart Catheterization and Cardiopulmonary Exercise Testing
31. Comparison of Safety of Sotalol Versus Amiodarone in Patients With Atrial Fibrillation and Coronary Artery Disease
32. Angiographic Outcomes in the PLATO Trial (Platelet Inhibition and Patient Outcomes)
33. Association of Beta-Blocker Use and Selectivity With Outcomes in Patients With Heart Failure and Chronic Obstructive Pulmonary Disease (from OPTIMIZE-HF)
34. LB-469807-04 EFFICACY AND SAFETY OF APIXABAN VERSUS ASPIRIN ACCORDING TO CHA2DS2-VASC SCORE IN PATIENTS WITH SUBCLINICAL ATRIAL FIBRILLATION IN ARTESIA
35. Hyponatremia and Long-Term Outcomes in Chronic Heart Failure—An Observational Study From the Duke Databank for Cardiovascular Diseases
36. GREATEST ABSOLUTE BENEFIT OF APIXABAN AND LIMITING ASPIRIN IS IN THOSE WITH COMORBIDITY: RESULTS FROM THE AUGUSTUS TRIAL
37. CLINICAL CHARACTERISTICS AND OUTCOMES AMONG ASIANS UNDERGOING ANTITHROMBOTIC THERAPY FOLLOWING ACUTE CORONARY SYNDROME
38. MODIFIED ON-TREATMENT ANALYSIS OF THE EFFECTS OF TORSEMIDE VS FUROSEMIDE AFTER DISCHARGE IN PATIENTS HOSPITALIZED WITH HEART FAILURE: RESULTS FROM TRANSFORM-HF
39. Hospital-Level Percutaneous Coronary Intervention Performance With Simulated Risk Avoidance
40. TCT-406 Effect of Antithrombotic Strategies on Total Outcome Events in Patients With Atrial Fibrillation After Acute Coronary Syndrome or Percutaneous Coronary Intervention: Insights From AUGUSTUS
41. ASSOCIATION OF HRCT PATTERNS AND TRANSPLANT-FREE SURVIVAL IN PATIENTS WITH PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES (ILDS) IN THE ILD-PRO REGISTRY
42. OBSTRUCTIVE HCM PATIENTS IN EXPLORER-HCM WITH HIGH LEFT VENTRICULAR FILLING PRESSURES HAD MORE SEVERE HEART FAILURE BUT SIMILAR OR GREATER RESPONSE TO MAVACAMTEN
43. WOMEN IN EXPLORER-HCM HAD MORE SEVERE HEART FAILURE AT BASELINE BUT SIMILAR, OR GREATER, RESPONSE TO MAVACAMTEN
44. THE EFFECT OF MAVACAMTEN TREATMENT FOR SYMPTOMATIC, OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN PATIENTS OF OLDER AGE AND LONGER DURATION OF DIAGNOSIS: ANALYSIS OF THE EXPLORER-HCM TRIAL
45. THE EFFECT OF MAVACAMTEN TREATMENT FOR SYMPTOMATIC, OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY IN PATIENTS WITH OR WITHOUT HYPERTENSION: ANALYSIS OF THE EXPLORER-HCM TRIAL
46. TCT-167 Utilization Rates and In-Hospital Outcomes Associated With Intravascular Imaging–Guided PCI in the USA: An Analysis of the NCDR CathPCI Registry
47. NATIONWIDE TRENDS AND OUTCOMES OF PERCUTANEOUS CORONARY INTERVENTIONS FOLLOWING DIAGNOSTIC ANGIOGRAPHY PERFORMED BY NON-INTERVENTIONAL CARDIOLOGIST VERSUS INTERVENTIONALISTS: INSIGHTS FROM THE CATHPCI REGISTRY
48. EFFECT OF APIXABAN VERSUS VITAMIN K ANTAGONIST AND ASPIRIN VERSUS PLACEBO ON DAYS ALIVE AND OUT OF HOSPITAL IN THE AUGUSTUS RANDOMIZED CONTROLLED TRIAL
49. Contemporary Use of Veno-arterial Extracorporeal Membrane Oxygenation: Insights from the Multicenter Rescue Registry
50. TRANSFUSIONS, WITH OR WITHOUT CONCOMITANT BLEEDING, ARE ASSOCIATED WITH HIGH SHORT-TERM MORTALITY IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH ORAL ANTICOAGULATION
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.